Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
ClearPoint Neuro, Inc. (CLPT) had Stock-Based Compensation of $8.18M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$36.97M |
|
$-25.54M |
|
$14.28M |
|
$22.69M |
|
$61.13M |
|
$-24.16M |
|
$-1.32M |
|
$-25.48M |
|
$-25.48M |
|
$-25.54M |
|
$-25.54M |
|
$-25.54M |
|
$-25.54M |
|
$-24.16M |
|
$-21.84M |
|
28.32M |
|
28.32M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$63.60M |
|
$2.62M |
|
$34.15M |
|
$97.75M |
|
$10.77M |
|
$49.08M |
|
$58.96M |
|
$69.73M |
|
$28.02M |
|
$6.63M |
|
$28.02M |
|
29.37M |
|
| Cash Flow Statement Financials | |
$-23.93M |
|
$0.61M |
|
$50.18M |
|
$20.10M |
|
$46.97M |
|
$26.87M |
|
|
Stock-Based Compensation |
$8.18M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.91 |
|
-- |
|
-- |
|
0.64 |
|
1.75 |
|
61.38% |
|
-65.36% |
|
-65.36% |
|
-59.08% |
|
-68.93% |
|
-69.08% |
|
$-24.45M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
1.71 |
|
5.65 |
|
64.66 |
|
-91.15% |
|
-385.45% |
|
-26.13% |
|
-33.13% |
|
$0.95 |
|
$-0.86 |
|
$-0.84 |
|